Search clinical trials for: Iodixanol, Ioversol, Iopromide

Total 67 results

GE Healthcare

Withdrawn

Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography

Diabetes Mellitus | Renal Impairment | Coronary Artery Disease (CAD)

United States, Germany
Yong Huo

Unknown

Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction (RIPE)

Kidney Failure, Chronic

China
GE Healthcare
Bayer; Guerbet/Liebel-Flarsheim

Withdrawn

Pediatric Risk of Hypothyroidism With Iodinated Contrast Media

Hypothyroidism
Seoul National University Bundang Hospital

Completed

Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide

Chronic Renal Insufficiency | Coronary Angiography

Korea, Republic of
Chinese PLA General Hospital

Completed

A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients (DIRECT)

Kidney Failure, Chronic

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Serum Thyroid Function After Iodinated Contrast Administration

Thyroid Dysfunction

China
Ospedale San Donato
Ospedale Le Scotte; Ospedale della Misericordia - Grosseto

Completed

Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI) (CONTRAST-AMI)

Acute Myocardial Infarction | Contrast Induced Nephropathy

Italy
Guerbet

Terminated

Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography (CINOPSIS CT)

Renal Impairment

United States
Seoul National University Hospital

Completed

Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT

Abdominal CT
Seoul National University Hospital

Completed

RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography

Kidney Failure

Korea, Republic of
University of Arizona

Terminated

An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer

Breast Cancer

United States
GE Healthcare

Completed

Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium

Coronary Artery Disease | ST-segment Elevation Myocardial Infarction

China, Korea, Republic of
GE Healthcare
i3 Statprobe

Completed

Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis

Patient Comfort and Safety

United States
Bayer

Completed

A Study to Learn More About the Safety of Ultravist in Children and in the Elderly

Hypersensitivity

Germany
Bayer

Completed

PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination (IMAGE)

Diagnostic Imaging

Poland, China, Germany, Hungary, Indonesia, Korea, Republic of, Malaysia, Saudi Arabia, Singapore, Thailand, Philippines, Taiwan, Italy, Moldova, Republic of, Romania, Russian Federation, Ukraine, Bosnia and Herzegovina, Pak... and more
Minneapolis Heart Institute Foundation

Recruiting

Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography (GE OCT)

Coronary Artery Disease | Contrast Media Reaction

United States
GE Healthcare
i3 Statprobe

Completed

Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography

Drug Safety

United States
GE Healthcare

Completed

Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)

Coronary Artery Disease

France
GE Healthcare

Completed

Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography

Coronary Artery Disease | Renal Impairment

Sweden
Bayer

Completed

Ultravist: Safety and Efficacy in Computed Tomography of Head and Body

Diagnostic Imaging | Computed Tomography

United States, Colombia, Korea, Republic of, India
Bracco Diagnostics, Inc

Terminated

Kidney Damage In Patients With Severe Fall In eGFR

Coronary Artery Stenosis

Canada
Oslo University Hospital

Completed

Novel Imaging of the Eustachian Tube; Patient Study (CT-ET)

Otitis Media With Effusion | Eustachian Tube Disorder

Norway
Instituto Dante Pazzanese de Cardiologia

Unknown

Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients (IDPC Trial) (IDPC)

Acute Kidney Failure
GE Healthcare
Medpace, Inc.; i3 Statprobe

Completed

Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)

Healthy

United States
Guerbet

Completed

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography (X-ACT)

Coronary Artery Disease

Spain, France, Germany, Italy, Switzerland
Bayer

Completed

A Study, Called UV Population, to Learn More About the Safety of the Study Drug Ultravist, Which is Given to Get Clearer X-ray Pictures, in People of Different Sexes, Races, and From Different Countries/Regions

Contrast Enhanced X-ray Based Examination

Germany
Washington University School of Medicine

Completed

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (GVHD)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Multiple Myeloma | Leukemia, Myelogenous, Chronic

United States
Deutsches Herzzentrum Muenchen

Completed

Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)

Renal Insufficiency, Chronic | Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Germany
GE Healthcare

Terminated

Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

Coronary Artery Disease

United States
GE Healthcare

Terminated

Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

Coronary Artery Disease

United States
Bracco Diagnostics, Inc

Completed

Kidney Damage in Patients With Moderate Fall in eGFR

Coronary Artery Stenosis

Canada, United States
Stanford University

Terminated

Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection

Pancreatic Cancer

United States
Seoul National University Hospital

Unknown

Role of Perfusion CT in Pancreatic Cancer

Neuroendocrine Carcinoma of Pancreas | Adenocarcinoma, Pancreas

Korea, Republic of
Bayer

Completed

A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting (RIGHT)

Multidetector Computed Tomography | Angiography

China
Bayer

Completed

Observational Study of Ultravist in Patients Requiring CECT (INDEX)

Diagnostic Imaging

China
Azienda Sanitaria Locale 9, Grosseto

Completed

Contrast-inDuced nephRotoxicity as Assessed by the KIdney Load-to-DAmage RElationship (DrKILDARE)

Contrast Induced Acute Kidney Injury

Italy
Marval Pharma Ltd.

Terminated

Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers

Healthy Volunteers

United States
Bracco Diagnostics, Inc

Completed

Isovue in Peripheral Digital Subtraction Angiography (DSA)

Peripheral Arterial Occlusive Disease

United States
Norwegian University of Science and Technology

Completed

DynaCT in Preoperative Imaging Before Insertion of Stentgraft (DynaCT)

Abdominal Aortic Aneurysm

Norway
Medical University of South Carolina
General Electric

Completed

Aortic Stenosis Pre-Transcatheter Aortic Valve Replacement (TAVR) Procedure CT Scan

Aortic Valve Stenosis

United States
Guangdong Provincial People's Hospital
First Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern... and other collaborators

Terminated

Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients (NEIHR)

Chronic Renal Disease

China
GE Healthcare
Quintiles, Inc.; Covance; ABX CRO; Examination Management Services Inc.; Averion...

Terminated

Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography

Diabetes Mellitus | Renal Insufficiency

United States, United Kingdom
Bayer

Completed

Study on the Risk of Allergy-like Reactions After Intra-arterial or Intra-venous Injection of the Marketed X-ray Contrast Medium Iopromid (UVIA)

Contrast Medium

Germany
Bayer

Completed

The Safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization (TRUST) (TRUST)

Angiocardiography

China
Bracco Diagnostics, Inc

Terminated

Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients (RECARE)

Diabetes Mellitus | Chronic Renal Impairment

United States
Bracco Diagnostics, Inc

Completed

Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA

Peripheral Arterial Occlusive Disease
Medical University of South Carolina
Bayer

Completed

VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography (VOLCANIC-CTA)

Cardiovascular Diseases | Coronary Artery Disease

United States
University of Washington
Guerbet

Withdrawn

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

Malignant Neoplasm in the Head and Neck | Metastatic Malignant Neoplasm in the Head and Neck

United States
Terumo BCT

Completed

In Vitro Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution

Healthy Volunteers

United States
NYU Langone Health
Guerbet

Completed

Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography

Coronary Artery Disease

United States

3

Subscribe